Literature DB >> 21880034

Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes.

Shunske Tanahashi1, Satoshi Yamamura, Masanori Nakagawa, Eishi Motomura, Motohiro Okada.   

Abstract

BACKGROUND AND
PURPOSE: Deficient transmission at the glutamate NMDA receptor is considered a key component of the pathophysiology of schizophrenia. However, the effects of antipsychotic drugs on the release of the endogenous NMDA receptor partial agonist, D-serine, remain to be clarified. EXPERIMENTAL APPROACH: We determined the interaction between antipsychotic drugs (clozapine and haloperidol) and transmission-modulating toxins (tetanus toxin, fluorocitrate, tetrodotoxin) on the release of L-glutamate and D-serine in the medial prefrontal cortex (mPFC) of freely moving rats, using microdialysis, and primary cultures of astrocytes using extreme high-pressure liquid chromatography. KEY
RESULTS: Release of L-glutamate and D-serine in the mPFC and in cultured astrocytes was inhibited by tetanus toxin (a synaptobrevin inhibitor) and fluorocitrate (a glial toxin), whereas tetrodotoxin (a voltage-sensitive Na(+) blocker) inhibited depolarization-induced L-glutamate release in the mPFC without affecting that of D-serine. Clozapine (1 and 5 mg·kg(-1)), but not haloperidol (0.5 and 1 mg·kg(-1)), dose-dependently increased L-glutamate and D-serine release from both astrocytes and mPFC. Clozapine-induced release of L-glutamate and D-serine was also reduced by tetanus toxin and fluorocitrate. Tetrodotoxin reduced clozapine-induced mPFC L-glutamate release but not that of D-serine. Clozapine-induced L-glutamate release preceded clozapine-induced D-serine release. MK-801 (a NMDA receptor antagonist) inhibited the delayed clozapine-induced L-glutamate release without affecting that of D-serine. CONCLUSIONS AND IMPLICATIONS: Clozapine predominantly activated glial exocytosis of D-serine, and this clozapine-induced D-serine release subsequently enhances neuronal L-glutamate release via NMDA receptor activation. The enhanced D-serine associated glial transmission seems a novel mechanism of action of clozapine but not haloperidol.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21880034      PMCID: PMC3372736          DOI: 10.1111/j.1476-5381.2011.01638.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Glutamatergic drugs for schizophrenia.

Authors:  H J Tuominen; J Tiihonen; K Wahlbeck
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

2.  Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems.

Authors:  M Okada; S Yoshida; G Zhu; S Hirose; S Kaneko
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Immunocytochemical analysis of D-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons.

Authors:  Susan M Williams; Claudia M Diaz; Lauren T Macnab; Robert K P Sullivan; David V Pow
Journal:  Glia       Date:  2006-03       Impact factor: 7.452

4.  Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission.

Authors:  Eduardo D Martín; Miriam Fernández; Gertrudis Perea; Olivier Pascual; Philip G Haydon; Alfonso Araque; Valentín Ceña
Journal:  Glia       Date:  2007-01-01       Impact factor: 7.452

5.  The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

Authors:  Robert W Buchanan; Daniel C Javitt; Stephen R Marder; Nina R Schooler; James M Gold; Robert P McMahon; Uriel Heresco-Levy; William T Carpenter
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

6.  Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.

Authors:  Lucila Kargieman; Noemí Santana; Guadalupe Mengod; Pau Celada; Francesc Artigas
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

7.  Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors.

Authors:  Elena Kartvelishvily; Maria Shleper; Livia Balan; Elena Dumin; Herman Wolosker
Journal:  J Biol Chem       Date:  2006-03-21       Impact factor: 5.157

Review 8.  Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site.

Authors:  Seong S Shim; Michael D Hammonds; Baik S Kee
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-09-27       Impact factor: 5.270

Review 9.  Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

Authors:  Daniel C Javitt
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

10.  Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic.

Authors:  Tomohiro Abekawa; Koki Ito; Tsukasa Koyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-26       Impact factor: 3.195

View more
  47 in total

1.  Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study.

Authors:  Kouji Fukuyama; Shunske Tanahashi; Tatsuya Hamaguchi; Masanori Nakagawa; Takashi Shiroyama; Eishi Motomura; Motohiro Okada
Journal:  Psychopharmacology (Berl)       Date:  2013-05-09       Impact factor: 4.530

2.  An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Authors:  Russell W Brown; Seth L Kirby; Adam R Denton; John M Dose; Elizabeth D Cummins; Wesley Drew Gill; Katherine C Burgess
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

3.  PAR1-activated astrocytes in the nucleus of the solitary tract stimulate adjacent neurons via NMDA receptors.

Authors:  Katie M Vance; Richard C Rogers; Gerlinda E Hermann
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

Review 4.  Role of astrocyte-synapse interactions in CNS disorders.

Authors:  Elena Blanco-Suárez; Alison L M Caldwell; Nicola J Allen
Journal:  J Physiol       Date:  2016-08-08       Impact factor: 5.182

Review 5.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

6.  Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.

Authors:  Jami L Saloman; Nicole N Scheff; Lindsey M Snyder; Sarah E Ross; Brian M Davis; Michael S Gold
Journal:  J Neurosci       Date:  2016-10-19       Impact factor: 6.167

7.  Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade.

Authors:  Motohiro Okada; Kouji Fukuyama; Yuto Ueda
Journal:  Br J Pharmacol       Date:  2019-09-15       Impact factor: 8.739

8.  Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.

Authors:  Kouji Fukuyama; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2018-10-06       Impact factor: 8.739

Review 9.  Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.

Authors:  Y Iwata; S Nakajima; T Suzuki; R S E Keefe; E Plitman; J K Chung; F Caravaggio; M Mimura; A Graff-Guerrero; H Uchida
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

10.  ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.

Authors:  Satoshi Yamamura; Masamitsu Hoshikawa; Kato Dai; Hiromitsu Saito; Noboru Suzuki; Osamu Niwa; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.